This Frontline Gastroenterology podcast discusses the FG review entitled 'Functional Dyspepsia or Gastroparesis?' with lead author Prof Daniel Keszthelyi, alongside Dr Dipesh Vasant and Dr Chris Black. From clear definitions and diagnostic pitfalls to what to investigate (and avoid), practical management, and how to communicate the diagnosis—essential listening for gastroenterologists and physicians managing such patients. Read this open-access manuscript on this link: https://fg.bmj.com/content/16/5/392

This special edition has been made to celebrate BASL's affiliation with Frontline Gastroenterology - listen to the team discuss the papers in this recent special edition.

Read the issue: https://fg.bmj.com/content/16/e1

Participants:

Dr Oliver Tavabie - Deputy Editor at Frontline Gastroenterology and Consultant Hepatologist at the Leeds Liver Unit Dr Louise China - Lead Associate Editor at Frontline Gastroenterology and Consultant Hepatologist at the Royal Free Dr Tim Cross - BASL President, Associate Editor at Frontline Gastroenterology and Consultant Hepatologist at the Royal Liverpool Hospital

We hope you enjoy the #FGPodcast. Please follow @‌FrontGastro_BMJ. Listen to our regular podcasts and subscribe in Apple Podcasts and Spotify. If you enjoy our podcast, please rate us on your chosen platform, and leave us a review on the Frontline Gastroenterology Podcast page on Apple Podcasts: https://podcasts.apple.com/gb/podcast/fg-podcast/id942944229

Historically patients with alcohol-related liver disease have received poor quality of care during their admission. In 2014, a guidance bundle was released by the the British Society of Gastroenterology (BSG) and British Association for the Study of the Liver (BASL) to address this issue. This toolkit has recently received an update to incorporate recent advances in care and improve its usability as well as accessibility.

A panel of guests join the podcast to discuss the perils of "bundle fatigue", the importance of buy-in for implementing guidance, and QI strategies for bringing the updated bundle successfully to your practice.

Dr Oliver Tavabie, Deputy Editor at FG and Hepatology Consultant at the Leeds Liver Unit along with Dr Kohilan Gananandan, Trainee Editor at FG and Hepatology Registrar Royal London Hospital, interview Professor Stuart McPherson and Drs Lynsey Corless and Giovanna McGinty. Professor Stuart McPherson is based at the Liver Unit at Newcastle Upon Tyne NHS Foundation Trust and is the deputy VP for Hepatology at the BSG. Dr Lynsey Corless is a Consultant Hepatologist at Hull Royal Infirmary and the NIHR Research Delivery Network National Specialty and Settings Lead for Hepatology. Dr Giovanna McGinty is a Specialist Gastroenterology Registrar at the North Bristol NHS Trust as well as an Associate Editor at FG. They are amongst the authors of the paper "Decompensated cirrhosis: an update of the BSG/BASL admission care bundle”, published online in Frontline Gastroenterology in April 2025.

We hope you enjoy the #FGPodcast. Please follow @‌FrontGastro_BMJ. Listen to our regular podcasts and subscribe in Apple Podcasts and Spotify. If you enjoy our podcast, please rate us on your chosen platform, and leave us a review on the Frontline Gastroenterology Podcast page on Apple Podcasts: https://podcasts.apple.com/gb/podcast/fg-podcast/id942944229

The use of anti-diabetic medications such as pioglitazone or GLP-1 receptor agonists in the management of metabolic dysfunction-associated steatotic liver disease (MASLD) is discussed in this podcast.

Dr Oliver Tavabie, Deputy Editor at FG and Hepatology Consultant at the Leeds Liver Unit, interviews Drs Scott Isaacs and Paul Brennan. Dr Scott Isaacs is the President of the American Association of Clinical Endocrinology and an Adjunct Associate Professor at Emory University School of Medicine, US. Dr Paul Brennan is a Senior Registrar and Honorary Research Fellow in Hepatology based at Ninewells Hospital, UK. They are authors of the paper "Role of anti-diabetic medications in the management of MASLD”, published online in Frontline Gastroenterology in February 2025.

We hope you enjoy the #FGPodcast. Please follow @‌FrontGastro_BMJ. Listen to our regular podcasts and subscribe in Apple Podcasts and Spotify. If you enjoy our podcast, please rate us on your chosen platform, and leave us a review on the Frontline Gastroenterology Podcast page on Apple Podcasts: https://podcasts.apple.com/gb/podcast/fg-podcast/id942944229

This podcast focusses on the Frontline Gastroenterology review paper on anti-obesity medications, authored by Dr Lisa Sharkey. From GLP1-RA GI side effects to nutritional risks, MASLD management and endoscopy considerations — this is a must-listen for every practicing and trainee gastroenterologist navigating the metabolic medicine revolution. Read the manuscript on this link: Anti-obesity drugs for the gastroenterologists

We hope you enjoy the #FGPodcast. Please follow @‌FrontGastro_BMJ. Listen to our regular podcasts and subscribe in Apple Podcasts and Spotify. If you enjoy our podcast, please rate us on your chosen platform, and leave us a review on the Frontline Gastroenterology Podcast page on iTunes: https://podcasts.apple.com/gb/podcast/fg-podcast/id942944229

This podcast is focused on the paper "Pancreatitis in children: practical management from the BSPGHAN Pancreatitis Working Group”, published online in Frontline Gastroenterology in February 2025. Dr Oliver Tavabie, Deputy Editor at FG and Hepatology Consultant at the Leeds Liver Unit, interviews the authors Drs Vangelis Giamouris and Tassos Grammatikopoulos from King's College Hospital Read the paper on the Frontline Gastroenterology website: https://fg.bmj.com/content/16/2/155

We hope you enjoy the #FGPodcast. Please follow @‌FrontGastro_BMJ. Listen to our regular podcasts and subscribe in Apple Podcasts and Spotify. If you enjoy our podcast, please rate us on your chosen platform, and leave us a review on the Frontline Gastroenterology Podcast page on iTunes: https://podcasts.apple.com/gb/podcast/fg-podcast/id942944229

Increased international travel has brought infectious diseases, once rarely encountered, into a broader setting. One such disease is Amoebiasis, which can be dangerous due to its possible presentation as inflammatory bowel disease. Deputy editor Dr. Aditi Kumar speaks with the authors of a recent paper on this subject, Dr. Joseph Cooney¹, Prof. Peter Chiodini² and Prof. Richard Pollok¹, titled "Recent advances in the diagnosis and management of amoebiasis"

1. Department of Gastroenterology, St George's University Hospitals NHS Foundation Trust, London, UK

2. Hospital for Tropical Diseases, London, London, UK

We hope you enjoy the #FGPodcast. Please follow @‌FrontGastro_BMJ. Listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please rate us on your chosen platform, and leave us a review on the Frontline Gastroenterology Podcast page on iTunes: https://podcasts.apple.com/gb/podcast/fg-podcast/id942944229